Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05141448 · ClinicalTrials.gov registry record
Visual Performance of Soft Contact Lenses With Myopia Control Optics
A clinical trial, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- 79
- Enrollment target
NCT05141448: Completed study, sponsored by Johnson & Johnson Vision Care.
NCT05141448 is a clinical trial that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05141448 has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
This is a multi-site, bilateral, dispensing, randomized, controlled, single-masked, 3x3 crossover study with a run-in period.
Primary Outcome
Visual performance was calculated as binocular contact lens-corrected distance visual acuity using a Logarithm of Minimal Angle of Resolution (logMAR) visual acuity scale. This was evaluated under high luminance and high contrast conditions (HLHC) at 4 meters from Early Treatment Diabetic Retinopathy Study (ETDRS) charts at the 2-week follow-up visit. Lower visual performance values indicate better vision. A value of 0.0 logMAR is equivalent to 20/20 Snellen Visual Acuity. The average visual per
Interventions
- DEVICE EMO-118
- DEVICE 1-Day Acuvue Moist
- DEVICE EMO-114
- DEVICE MiSight® 1 day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2021-11-22 |
| Est. Completion | 2022-04-01 |
What the finished NCT05141448 record still lists
NCT05141448 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which EMO-118 is the first listed.
NCT05141448 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05141448 about?
NCT05141448 is a clinical study titled "Visual Performance of Soft Contact Lenses With Myopia Control Optics". This is a multi-site, bilateral, dispensing, randomized, controlled, single-masked, 3x3 crossover study with a run-in period.
What is the current status of trial NCT05141448?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2021-11-22. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT05141448?
The interventions under investigation include: EMO-118 (DEVICE), 1-Day Acuvue Moist (DEVICE), EMO-114 (DEVICE), MiSight® 1 day (DEVICE).
Who is sponsoring clinical trial NCT05141448?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI